Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
Background: In adults aged ≥60 years, two doses of the herpes zoster subunit vaccine (HZ/su; 50 µg varicella-zoster virus glycoprotein E [gE] and AS01B Adjuvant System) elicited humoral and cell-mediated immune responses persisting for at least six years. We assessed immunogenicity nine years post-i...
Saved in:
Main Authors: | Tino F. Schwarz (Author), Stephanie Volpe (Author), Gregory Catteau (Author), Roman Chlibek (Author), Marie Pierre David (Author), Jan Hendrik Richardus (Author), Himal Lal (Author), Lidia Oostvogels (Author), Karlis Pauksens (Author), Stephanie Ravault (Author), Lars Rombo (Author), Gerard Sonder (Author), Jan Smetana (Author), Thomas Heineman (Author), Adriana Bastidas (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly
by: Peter Vink, et al.
Published: (2017) -
Vaccine profile of herpes zoster (HZ/su) subunit vaccine
by: Anthony L. Cunningham, et al.
Published: (2017) -
Influenza vaccination in the elderly
by: Jan Smetana, et al.
Published: (2018) -
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
by: Lidia Oostvogels, et al.
Published: (2019) -
Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma; is the B-cell response preserved?
by: Anna Ljunghill Hedberg, et al.
Published: (2022)